Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.8 NOK | +8.15% | +8.74% | -4.10% |
04-29 | Gentian Diagnostics Asa Resolves to Elect Ms. Hilja Ibert as Chairperson of the Board of Directors | CI |
04-29 | Gentian Diagnostics ASA Appoints Mr. Njaal Kind as Acting CEO | CI |
Sales 2024 * | 171M 15.48M 0 | Sales 2025 * | 203M 18.42M 0 | Capitalization | 614M 55.72M 0 |
---|---|---|---|---|---|
Net income 2024 * | -11M -999K - | Net income 2025 * | -6M -545K - | EV / Sales 2024 * | 3.4 x |
Net cash position 2024 * | 34M 3.09M 0 | Net cash position 2025 * | 15M 1.36M 0 | EV / Sales 2025 * | 2.95 x |
P/E ratio 2024 * |
-53.2
x | P/E ratio 2025 * |
-93.5
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.85% |
Latest transcript on Gentian Diagnostics
1 day | +8.15% | ||
1 week | +8.74% | ||
Current month | +2.58% | ||
1 month | +2.58% | ||
3 months | -2.93% | ||
6 months | -0.25% | ||
Current year | -4.10% |
Managers | Title | Age | Since |
---|---|---|---|
Hilja Ibert
CEO | Chief Executive Officer | - | 18-07-15 |
Njaal Kind
DFI | Director of Finance/CFO | 52 | 18-01-01 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Settevik
CHM | Chairman | 64 | - |
Fredrik Thoresen
BRD | Director/Board Member | 44 | - |
Director/Board Member | 60 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 39.8 | +8.15% | 15,990 |
24-04-26 | 36.8 | -2.13% | 15,068 |
24-04-25 | 37.6 | 0.00% | 0 |
24-04-24 | 37.6 | 0.00% | 2,850 |
24-04-23 | 37.6 | +2.73% | 125 |
Real-time Oslo Bors, April 29, 2024 at 10:45 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.10% | 55.83M | |
+1.69% | 12.95B | |
-7.57% | 7.84B | |
+3.22% | 5.5B | |
+0.93% | 4.61B | |
+8.48% | 4.61B | |
+9.21% | 2.66B | |
-13.87% | 2.08B | |
-11.63% | 1.72B | |
+3.45% | 1.79B |
- Stock Market
- Equities
- GENT Stock